Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Tokyo  >  Terumo Corp    4543   JP3546800008

TERUMO CORP (4543)
My previous session
Most popular
  Report  
 SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
OFFRE
Financials (JPY)
Sales 2019 609 B
EBIT 2019 -
Net income 2019 81 162 M
Debt 2019 123 B
Yield 2019 0,83%
Sales 2020 648 B
EBIT 2020 -
Net income 2020 90 308 M
Debt 2020 65 565 M
Yield 2020 0,90%
P/E ratio 2019 29,09
P/E ratio 2020 26,13
EV / Sales2019 4,33x
EV / Sales2020 3,98x
Capitalization 2 514 B
More Financials
Company
Terumo Corp. engages in the manufacturing and sale of medical products and equipment.It operates through the following segments: General Hospital, Cardiac & Vascular, and Blood Management.The General Hospital segment produces, supplies, leases, and sells hospital equipment, pharmaceutical, home... 
More about the company
Surperformance© ratings of Terumo Corp
Trading Rating : Investor Rating :
More Ratings
Latest news on TERUMO CORP
04:13aTERUMO : to Launch the Ultimaster Tansei Drug Eluting Stent in Japan
PU
08/29TERUMO : Notice Concerning the Determination of Details of Issuance of Stock Opt..
PU
08/16TERUMO : President and CEO of Terumo BCT David Perez to Retire after FY 2018; An..
PU
08/07TERUMO : Old Bridge student receives scholarship from Terumo Americas Holding
AQ
08/06TERUMO : Affiliate in China to Receive an Approval for PD solution
PU
08/02TERUMO : Patent Issued for Living Body Tissue Three-Dimensional Model And Produc..
AQ
08/01TERUMO : Supply and Delivery of Medical, X-ray, Laboratory and Reagent Supplies ..
AQ
07/31TERUMO : Announces Receiving European Medicines Agency GMP Certification for the..
PU
07/25TERUMO : Supply and Delivery of Various Medical and Laboratory Supplies
AQ
07/24TERUMO : Acquires China-based Essen Technology To Enter Drug-eluting Stent Marke..
PU
More news
Sector news : Medical Equipment, Supplies & Distribution - NEC
09/13Smiths and ICU Medical healthcare merger talks collapse
RE
09/11STRYKER : to Buy Invuity for About $190 Million
DJ
09/10EXCLUSIVE - CAMPBELL SOUP STEPS UP C : sources
RE
09/10EXCLUSIVE : Campbell Soup steps up CEO search, COO a contender - sources
RE
09/07THERMO FISHER SCIENTIFIC : to Buy Becton Dickinson's Advanced Bioprocessing Unit..
DJ
More sector news : Medical Equipment, Supplies & Distribution - NEC
Latest Tweets
08/29Terumo : Notice Concerning the Determination of Details of Issuance of Stock .. 
08/16David Perez to Retire as President and CEO of Terumo BCT on March 31, 2019; A.. 
08/06Terumo : Affiliate in China to Receive an Approval for PD solution  
07/24Terumo : Acquires China-based Essen Technology To Enter Drug-eluting Stent Ma.. 
07/18U.S. FDA Approves Terumo BCT’s Sodium Citrate 4% w/v Anticoagulant Solution A.. 
More tweets
Qtime:17
News from SeekingAlpha
08/09Terumo Corp. ADR 2019 Q1 - Results - Earnings Call Slides 
07/29WEEK IN REVIEW : Long Hill Capital Closes $265 Million Fund For China Healthcare 
07/25KEMET Needs To Make Another Acquisition 
02/09Terumo Corp. ADR 2018 Q3 - Results - Earnings Call Slides 
2017HAEMONETICS : Revisiting The Company's Outlook 
Chart TERUMO CORP
Duration : Period :
Terumo Corp Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends TERUMO CORP
Short TermMid-TermLong Term
TrendsBullishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 18
Average target price 6 686  JPY
Spread / Average Target 0,99%
EPS Revisions
Managers
NameTitle
Shinjiro Sato President, CEO & Representative Director
Takayoshi Mimura Chairman
Ryo Nishihata Chief Accounting & Financial Officer
Hiroaki Kasukawa CTO, Executive Officer, GM-Research & Development
Katsuya Takeuchi Executive Officer & Chief Information Officer
Sector and Competitors
1st jan.Capitalization (M$)
TERUMO CORP23.05%21 832
MEDTRONIC PLC19.98%129 690
BAXTER INTERNATIONAL19.18%41 160
ALIGN TECHNOLOGY70.29%30 391
ZIMMER BIOMET HOLDINGS8.10%26 362
HOYA CORPORATION15.69%22 439